AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34641819 — intervention group
Group type: COMPARATOR
Intervention: Usual-care control group (no counselling).
Number of subjects: 43
Study 35038612 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1 g before skin incision and after placental delivery)
Number of subjects: 110
Study 35038612 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 35038612 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 110
Study 35211291 — intervention group
Group type: EXPERIMENTAL
Intervention: Brace (n=30)
Number of subjects: 60
Study 35211291 — intervention group
Group type: COMPARATOR
Intervention: Traditional cast (n=30)
Number of subjects: 60
Study 35211291 — intervention group
Group type: EXPERIMENTAL
Intervention: Brace (n=27)
Number of subjects: 60
Study 35211291 — intervention group
Group type: COMPARATOR
Intervention: Traditional cast (n=27)
Number of subjects: 60
Study 36314130 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary virtual HF intervention providing GDMT recommendations
Number of subjects: 91
Study 36314130 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 91
Study 36314130 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary virtual HF intervention
Number of subjects: 91
Study 33459692 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing exercises combined with dynamic upper- and lower-extremity exercises
Number of subjects: 26
Study 33459692 — intervention group
Group type: COMPARATOR
Intervention: Dynamic upper- and lower-extremity exercises (Control)
Number of subjects: 26
Study 34543829 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 36
Study 34543829 — intervention group
Group type: EXPERIMENTAL
Intervention: Fusion Protein Inhibitor (FPI)
Number of subjects: 36
Study 34543829 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen and FPI (combined therapy)
Number of subjects: 36
Study 34543829 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 32447830 — intervention group
Group type: EXPERIMENTAL
Intervention: 650 usec 1064nm Nd:YAG laser
Number of subjects: 20
Study 32447830 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 20
Study 34051585 — intervention group
Group type: EXPERIMENTAL
Intervention: CuidaCare intervention (home-based, nurse-led intervention including cognitive restructuring, health education, and emotional support)
Number of subjects: 224
Study 34051585 — intervention group
Group type: EXPERIMENTAL
Intervention: CuidaCare intervention
Number of subjects: 224
Study 34051585 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 224
Study 35712291 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinect-based interactive fall intervention system (40 min/session × 2 sessions/week × 8 weeks)
Number of subjects: 30
Study 35712291 — intervention group
Group type: COMPARATOR
Intervention: Control group (maintained habitual activities)
Number of subjects: 30
Study 35712291 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinect-based interactive fall intervention system
Number of subjects: 30
Study 34232005 — intervention group
Group type: EXPERIMENTAL
Intervention: HP/TAZ (halobetasol propionate 0.01% and tazarotene 0.045%) lotion, applied once daily for 8 weeks
Number of subjects: 418
Study 34232005 — intervention group
Group type: COMPARATOR
Intervention: Vehicle lotion, applied once daily for 8 weeks
Number of subjects: 418
Study 34232005 — intervention group
Group type: EXPERIMENTAL
Intervention: HP/TAZ
Number of subjects: 418
Study 33888093 — intervention group
Group type: EXPERIMENTAL
Intervention: Claims-based definition of RA
Number of subjects: 334
Study 32074798 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic exploration combined with abdominal exfoliative cytology
Number of subjects: 225
Study 32074798 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal hyperthermic chemotherapy + conversion therapy
Number of subjects: 225
Study 36007870 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma (CP) therapy, 300 mL
Number of subjects: 421
Study 36007870 — intervention group
Group type: COMPARATOR
Intervention: Control (non-CP)
Number of subjects: 421
Study 33478335 — intervention group
Group type: EXPERIMENTAL
Intervention: VBN + EBUS
Number of subjects: 105
Study 33478335 — intervention group
Group type: COMPARATOR
Intervention: EBUS
Number of subjects: 105
Study 36241502 — intervention group
Group type: EXPERIMENTAL
Intervention: New-age music administered twice a day for 7 days postoperatively using headphones.
Number of subjects: 200
Study 36241502 — intervention group
Group type: COMPARATOR
Intervention: Control group (no music intervention).
Number of subjects: 200
Study 36241502 — intervention group
Group type: EXPERIMENTAL
Intervention: New-age music intervention.
Number of subjects: 200
Study 35466040 — intervention group
Group type: EXPERIMENTAL
Intervention: Food only
Number of subjects: 30
Study 35466040 — intervention group
Group type: EXPERIMENTAL
Intervention: Food plus water
Number of subjects: 30
Study 35466040 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypohydration plus water
Number of subjects: 30
Study 35466040 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypohydration
Number of subjects: 30
Study 32090516 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet-induced weight loss intervention with a prescribed energy deficit of approximately 500 kcal/d
Number of subjects: 85
Study 32090516 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet-induced weight loss intervention
Number of subjects: 85
Study 32090516 — intervention group
Group type: COMPARATOR
Intervention: Baseline comparison of miR-122-5p levels
Number of subjects: 85
Study 36446694 — intervention group
Group type: EXPERIMENTAL
Intervention: Solution-Focused Approach (SFA)
Number of subjects: 128
Study 36446694 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 128
Study 33205372 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01% atropine + spectacles (SA group)
Number of subjects: 80
Study 33205372 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01% atropine + OK lenses (OKA group)
Number of subjects: 80
Study 33205372 — intervention group
Group type: COMPARATOR
Intervention: Spectacles only (S group)
Number of subjects: 80
Study 33205372 — intervention group
Group type: COMPARATOR
Intervention: OK lenses only (OK group)
Number of subjects: 80
Study 35842583 — intervention group
Group type: EXPERIMENTAL
Intervention: Excimer laser ablation combined with drug-coated balloon (ELA + DCB)
Number of subjects: 0
Study 35842583 — intervention group
Group type: COMPARATOR
Intervention: Drug-coated balloon (DCB) alone
Number of subjects: 0
Study 32877795 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy plus surgery (CRT + S group)
Number of subjects: 411
Study 32877795 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (S group)
Number of subjects: 411
Study 35023049 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training for 16 weeks
Number of subjects: 52
Study 35023049 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined training (resistance and aerobic) for 8 weeks after 8 weeks of aerobic training
Number of subjects: 52
Study 35023049 — intervention group
Group type: COMPARATOR
Intervention: Control group performing low-intensity water-based therapeutic exercises
Number of subjects: 52
Study 32131656 — intervention group
Group type: EXPERIMENTAL
Intervention: SWC + Dermalix (Dx)
Number of subjects: 48
Study 32131656 — intervention group
Group type: COMPARATOR
Intervention: Standard Wound Care (SWC)
Number of subjects: 48
Study 35372632 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrus aurantium essential oil (2 drops, twice a day, for 4 consecutive days a week, for 4 weeks)
Number of subjects: 80
Study 35372632 — intervention group
Group type: COMPARATOR
Intervention: Almond oil (same dosage and duration as intervention)
Number of subjects: 80
Study 35372632 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrus aurantium essential oil
Number of subjects: 80
Study 32892358 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiving few likes during a standardized social media interaction
Number of subjects: 613
Study 32892358 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiving fewer likes
Number of subjects: 613
Study 35915754 — intervention group
Group type: EXPERIMENTAL
Intervention: Outdoor running (OT)
Number of subjects: 28
Study 35915754 — intervention group
Group type: COMPARATOR
Intervention: Treadmill running (TT)
Number of subjects: 28
Study 34801353 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense dose-dense epirubicin, paclitaxel, cyclophosphamide (iddEPC)
Number of subjects: 945
Study 34801353 — intervention group
Group type: COMPARATOR
Intervention: Weekly paclitaxel, non-pegylated liposomal doxorubicin (plus carboplatin) (PM(Cb))
Number of subjects: 945
Study 32112555 — intervention group
Group type: EXPERIMENTAL
Intervention: Music Therapy (MT) combined with Skin-to-Skin Care (SSC)
Number of subjects: 72
Study 32112555 — intervention group
Group type: COMPARATOR
Intervention: Skin-to-Skin Care (SSC) alone
Number of subjects: 72
Study 35788397 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive self-ligating brackets
Number of subjects: 66
Study 35788397 — intervention group
Group type: EXPERIMENTAL
Intervention: Active self-ligating brackets
Number of subjects: 66
Study 35788397 — intervention group
Group type: COMPARATOR
Intervention: Conventional brackets (control)
Number of subjects: 66
Study 35788397 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 66
Study 34179932 — intervention group
Group type: EXPERIMENTAL
Intervention: HP-HMB (Ensure® Plus Advance containing 3g HMB)
Number of subjects: 70
Study 34179932 — intervention group
Group type: COMPARATOR
Intervention: Control (professional nutritional counselling for sufficient protein intake)
Number of subjects: 70
Study 32235251 — intervention group
Group type: EXPERIMENTAL
Intervention: 27-gauge surgery
Number of subjects: 68
Study 32235251 — intervention group
Group type: COMPARATOR
Intervention: 23-gauge surgery
Number of subjects: 68
Study 35535555 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab plus FLOT chemotherapy
Number of subjects: 900
Study 35535555 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant durvalumab monotherapy
Number of subjects: 900
Study 35535555 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus FLOT chemotherapy
Number of subjects: 900
Study 33571302 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing First
Number of subjects: 200
Study 33571302 — intervention group
Group type: COMPARATOR
Intervention: Treatment As Usual
Number of subjects: 200
Study 35572838 — intervention group
Group type: EXPERIMENTAL
Intervention: Submental island flap with psychological intervention
Number of subjects: 180
Study 35572838 — intervention group
Group type: EXPERIMENTAL
Intervention: Free flap with psychological intervention
Number of subjects: 180
Study 35572838 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing intervention (Control group C)
Number of subjects: 180
Study 34401393 — intervention group
Group type: EXPERIMENTAL
Intervention: eLearning MHFA course
Number of subjects: 608
Study 34401393 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended MHFA course
Number of subjects: 608
Study 34401393 — intervention group
Group type: COMPARATOR
Intervention: Red Cross eLearning Provide First Aid (PFA) (control)
Number of subjects: 608
Study 34436655 — intervention group
Group type: EXPERIMENTAL
Intervention: Massively parallel sequencing (MPS) using the PowerSeq 46Y kit (Promega)
Number of subjects: 247
Study 32441786 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone treatment (n=18)
Number of subjects: 34
Study 32441786 — intervention group
Group type: COMPARATOR
Intervention: No methylprednisolone treatment (n=16)
Number of subjects: 34
Study 34076349 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher socioeconomic status (years of schooling, college or university degree, household income)
Number of subjects: 0
Study 34076349 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarettes smoked per day, time spent watching TV, polyunsaturated fatty acids, docosapentaenoic acid, eicosapentaenoic acid, arachidonic acid in blood
Number of subjects: 0
Study 34076349 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum vitamin A1, copper in blood, docosahexaenoic acid in blood, body fat percentage
Number of subjects: 0
Study 33989763 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation (109 CFU of 12 types of probiotics + fructooligosaccharides prebiotic), twice per day for 12 weeks
Number of subjects: 69
Study 33989763 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplementation, twice per day for 12 weeks
Number of subjects: 69
Study 32007393 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC) - four cycles of 5 min/5 min arm cuff inflation/deflation immediately prior to surgery
Number of subjects: 50
Study 32007393 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 50
Study 32007393 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 50
Study 35746969 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS over right inferior frontal cortex (rIFC) combined with cognitive training (CT)
Number of subjects: 50
Study 35746969 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 50
Study 34785365 — intervention group
Group type: EXPERIMENTAL
Intervention: Real M1‐rTMS treatment (10Hz, 10 daily treatments over 2 weeks)
Number of subjects: 27
Study 34785365 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 27
Study 32643163 — intervention group
Group type: EXPERIMENTAL
Intervention: IMPaCT intervention (standardized community health worker intervention)
Number of subjects: 1340
Study 32643163 — intervention group
Group type: EXPERIMENTAL
Intervention: IMPaCT intervention
Number of subjects: 1340
Study 32643163 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1340
Study 35685661 — intervention group
Group type: EXPERIMENTAL
Intervention: Berberine hydrochloride plus conventional treatment
Number of subjects: 68
Study 35685661 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 68
Study 33486392 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Recovery Therapy (SRT) + Early intervention
Number of subjects: 123
Study 33486392 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU) - early intervention care
Number of subjects: 123
Study 33486392 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Recovery Therapy (SRT)
Number of subjects: 123
Study 32074256 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus implantable loop recorder (ILR) with 24-hour Holter ECG monitoring (n = 17)
Number of subjects: 40
Study 32074256 — intervention group
Group type: COMPARATOR
Intervention: Standard care (24-hour Holter ECG monitoring) (n = 20)
Number of subjects: 40
Study 32074256 — intervention group
Group type: EXPERIMENTAL
Intervention: ILR (n = 17)
Number of subjects: 40
Study 35068440 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided fine-needle puncture (USNP)
Number of subjects: 62
Study 35068440 — intervention group
Group type: COMPARATOR
Intervention: Radial shock wave therapy (RSWT)
Number of subjects: 62
Study 35068440 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatments (COMB)
Number of subjects: 62
Study 33933014 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful movements
Number of subjects: 550
Study 33933014 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine programme
Number of subjects: 550
Study 33933014 — intervention group
Group type: COMPARATOR
Intervention: Telemedicine
Number of subjects: 550
Study 35313858 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 131
Study 35313858 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 131
Study 35313858 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 131
Study 35313858 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrates
Number of subjects: 131
Study 33125033 — intervention group
Group type: EXPERIMENTAL
Intervention: OMT/VRT
Number of subjects: 23
Study 33125033 — intervention group
Group type: EXPERIMENTAL
Intervention: OMT
Number of subjects: 23
Study 33125033 — intervention group
Group type: COMPARATOR
Intervention: VRT
Number of subjects: 23
Study 32583886 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower achieved LDL-C in total, low, and high intensity statin users
Number of subjects: 0
Study 32583886 — intervention group
Group type: EXPERIMENTAL
Intervention: Middle tertile of matched baseline LDL-C
Number of subjects: 0
Study 32583886 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest tertile of matched baseline LDL-C
Number of subjects: 0
Study 32583886 — intervention group
Group type: COMPARATOR
Intervention: Statin intensity
Number of subjects: 0
Study 34528669 — intervention group
Group type: COMPARATOR
Intervention: Standard Treatment Group (targeted SBP <140 mm Hg)
Number of subjects: 9361
Study 34528669 — intervention group
Group type: COMPARATOR
Intervention: Intensive Treatment Group (targeted SBP <120 mm Hg)
Number of subjects: 9361
Study 34528669 — intervention group
Group type: EXPERIMENTAL
Intervention: Low adherence
Number of subjects: 9361
Study 34528669 — intervention group
Group type: EXPERIMENTAL
Intervention: High adherence
Number of subjects: 9361
Study 34528669 — intervention group
Group type: COMPARATOR
Intervention: MMAS-8 over time
Number of subjects: 9361
Study 34528669 — intervention group
Group type: COMPARATOR
Intervention: Primary outcome (composite of myocardial infarction, other acute coronary syndromes, stroke, heart failure, or death from cardiovascular causes)
Number of subjects: 9361
Study 34250456 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated SARS-CoV-2 vaccine (2.5, 5, or 10 µg) in a three-dose schedule on days 0, 28, and 56
Number of subjects: 1120
Study 34250456 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated SARS-CoV-2 vaccine (5 µg) in a two-dose schedule on days 0 and 14/21/28
Number of subjects: 1120
Study 34250456 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated SARS-CoV-2 vaccine (10 µg) in a one-dose schedule
Number of subjects: 1120
Study 34250456 — intervention group
Group type: COMPARATOR
Intervention: Placebo (aluminum hydroxide adjuvant)
Number of subjects: 1120
Study 34121635 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural implantation
Number of subjects: 40
Study 34121635 — intervention group
Group type: COMPARATOR
Intervention: Sham surgery
Number of subjects: 40
Study 34271286 — intervention group
Group type: EXPERIMENTAL
Intervention: hCPAP
Number of subjects: 224
Study 34271286 — intervention group
Group type: COMPARATOR
Intervention: fCPAP
Number of subjects: 224
Study 36237142 — intervention group
Group type: EXPERIMENTAL
Intervention: TNS A+ serum (topical growth factor serum), applied twice daily for 12 weeks
Number of subjects: 17
Study 34613430 — intervention group
Group type: EXPERIMENTAL
Intervention: LSD (13 ?g)
Number of subjects: 22
Study 34613430 — intervention group
Group type: EXPERIMENTAL
Intervention: LSD (26 ?g)
Number of subjects: 22
Study 34613430 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 33220010 — intervention group
Group type: EXPERIMENTAL
Intervention: DecoDisCo algorithm for distortion correction
Number of subjects: 0
Study 33220010 — intervention group
Group type: COMPARATOR
Intervention: Multifrequency reconstruction
Number of subjects: 0
Study 33220010 — intervention group
Group type: COMPARATOR
Intervention: Other distortion-correction approaches
Number of subjects: 0
Study 35030040 — intervention group
Group type: EXPERIMENTAL
Intervention: Active PBMT
Number of subjects: 50
Study 35030040 — intervention group
Group type: COMPARATOR
Intervention: Placebo PBMT
Number of subjects: 50
Study 33419444 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone fundoscopy
Number of subjects: 146
Study 33419444 — intervention group
Group type: COMPARATOR
Intervention: Non-mydriatic fundus camera
Number of subjects: 146
Study 33419444 — intervention group
Group type: COMPARATOR
Intervention: Direct fundoscopy
Number of subjects: 146
Study 33336360 — intervention group
Group type: EXPERIMENTAL
Intervention: Titrated oral misoprostol solution (OMS)
Number of subjects: 4395
Study 33336360 — intervention group
Group type: COMPARATOR
Intervention: Vaginal dinoprostone
Number of subjects: 4395
Study 32961319 — intervention group
Group type: EXPERIMENTAL
Intervention: NAVIFY Mutation Profiler
Number of subjects: 37
Study 35102369 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% ER high-nutrient-quality diet
Number of subjects: 110
Study 35102369 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% ER low-nutrient-quality diet
Number of subjects: 110
Study 35102369 — intervention group
Group type: COMPARATOR
Intervention: Habitual diet
Number of subjects: 110
Study 33845878 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional and respiratory multidisciplinary rehabilitation protocol (6 days per week, 15 minutes, twice per day) during hospital stay and home exercises for 12 weeks post-discharge.
Number of subjects: 80
Study 33845878 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (usual medical and nursing care in the ICU).
Number of subjects: 80
Study 32892604 — intervention group
Group type: EXPERIMENTAL
Intervention: SGB group
Number of subjects: 60
Study 32892604 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 33422518 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial access (RA)
Number of subjects: 2285
Study 33422518 — intervention group
Group type: COMPARATOR
Intervention: Femoral access (FA)
Number of subjects: 2285
Study 33355818 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-Isometric Relaxation
Number of subjects: 45
Study 33355818 — intervention group
Group type: EXPERIMENTAL
Intervention: LASER
Number of subjects: 45
Study 33355818 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 45
Study 34626075 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed test for comparing two binomial proportions
Number of subjects: 0
Study 34626075 — intervention group
Group type: COMPARATOR
Intervention: Existing methods (standard z-test and Jung's test)
Number of subjects: 0
Study 34626075 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed method
Number of subjects: 0
Study 34758875 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress management training program (8 sessions, 1.5 hours each, twice a week)
Number of subjects: 60